Nuvation Bio Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +76,451.9% | +83.4% | +249.9% | -13.4% | -7.5% | -13.0% | +10.0% | |
| – | +75,776.6% | +84.1% | +249.9% | -13.6% | -7.6% | -14.6% | +8.6% | |
| – | +2,413.8% | +757.7% | +345.0% | -23.7% | -57.8% | -16.2% | +359.3% | |
| – | +86,037.7% | +81.5% | +254.8% | -13.6% | -7.5% | -17.8% | +5.3% | |
| – | – | +31.9% | +178.3% | -18.2% | +49.0% | +340.1% | +18.8% | |
| – | – | – | +21,885.8% | – | – | – | – | |
| – | – | +6.5% | +431.5% | -75.6% | – | – | – | |
| – | – | – | – | – | – | – | +142.6% | |
| – | +255.2% | +109.4% | +349.5% | -43.4% | -4.1% | +369.6% | +276.3% | |
| – | +255.2% | +104.5% | +158.4% | -22.2% | +6.2% | +316.8% | +41.2% | |
| – | – | – | – | +39.7% | +63.5% | +302.9% | -4.3% | |
| – | +2,345.8% | +6.9% | +80.8% | -45.5% | +3.3% | +187.4% | +49.3% | |
| – | – | – | – | – | – | – | – | |
| – | – | +82.7% | +246.8% | -12.2% | -7.6% | -23.4% | -34.1% | |
| – | – | – | – | – | – | – | – | |
| – | +12.5% | +5.3% | -9.1% | +9.5% | +1.0% | +22.8% | +27.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.